| |
|
|
|
Worel N, Rosskopf K, Neumeister P, Kasparu H, Nachbaur D, Russ G, Namberger K, Witt V, Schloegl E, Zojer N, Linkesch W, Kalhs P, Greinix HT. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program. Transfusion. 2011;51:968-975. Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; Thérapie cellulaire ; maj-2011-11
|
|
|
Worel N, Panzer S, Reesink HW, Linkesch W, Dickmeiss E, Fischer-Nielsen A, Holig K, Stachel D, Zimmermann R, Holter W, Coluccia P, Brilhante D, Watz E, Sigle JP, Gratwohl A, Buser A, Arslan O, Regan F, Edwards M. Transfusion policy in ABO-incompatible allogeneic stem cell transplantation. Vox Sang. 2010;98:455-467. Thèmes : Transplantation ; Thérapie cellulaire ; maj-2010-09
|
|
|
Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, Strunk D. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood. 2009;113:6716-6725. Thèmes : Thérapie cellulaire ; maj-2009-10
|
|
|
|
|
|
|
|